US4880635B1
(en)
*
|
1984-08-08 |
1996-07-02 |
Liposome Company |
Dehydrated liposomes
|
CS263203B1
(en)
*
|
1986-07-22 |
1989-04-14 |
Sulc Jiri |
Soft intraocular lenses
|
US5032109A
(en)
*
|
1987-02-10 |
1991-07-16 |
Drug Delivery Systems Inc. |
Electrolytic transdermal delivery of polypeptides
|
US4878892A
(en)
*
|
1987-02-10 |
1989-11-07 |
Drug Delivery Systems Inc. |
Electrolytic transdermal delivery of polypeptides
|
US5110600A
(en)
*
|
1988-01-25 |
1992-05-05 |
The Regents Of The University Of California |
Method of treating viral infections with amino acid analogs
|
US5192316A
(en)
*
|
1988-02-16 |
1993-03-09 |
Allergan, Inc. |
Ocular device
|
US4990336A
(en)
*
|
1989-02-08 |
1991-02-05 |
Biosearch, Inc. |
Sustained release dosage form
|
US5760261A
(en)
*
|
1990-02-28 |
1998-06-02 |
Guttag; Alvin |
Higher fatty acid derivatives of salicylic acid and salts thereof
|
US5173302A
(en)
*
|
1990-09-28 |
1992-12-22 |
Medtronic, Inc. |
Hydrophilic pressure sensitive adhesive for topical administration of hydrophobic drugs
|
ATE193654T1
(de)
*
|
1991-08-16 |
2000-06-15 |
Miles A Galin |
Mit arzneimittel überzogenes lichtbrechendes implantat für die vordere augenkammer
|
WO1993014133A1
(en)
*
|
1992-01-15 |
1993-07-22 |
Allergan, Inc. |
Hydrogel compositions and structures made from same
|
US5643928A
(en)
*
|
1992-10-21 |
1997-07-01 |
Pharmaco Behavioral Associates, Inc. |
Human body weight management
|
US5596007A
(en)
*
|
1992-05-18 |
1997-01-21 |
Pharmaco Behavioral Associates, Inc. |
Therapeutic method to alleviate the craving associated with cessation of tobacco with cotinine
|
US5612357A
(en)
*
|
1992-05-18 |
1997-03-18 |
Pharmaco Behavioral Associates, Inc. |
Use of cotinine to assist in the cessation of tobacco smoking
|
US5869505A
(en)
*
|
1993-02-02 |
1999-02-09 |
Keenan; Robert M. |
Nicotine metabolites and nicotine dependence
|
PT659073E
(pt)
*
|
1992-09-10 |
2002-06-28 |
Childrens Medical Center |
Matrizes polimericas biodegradaveis para entrega sustentada de agentes anestesicos locais
|
US5700485A
(en)
*
|
1992-09-10 |
1997-12-23 |
Children's Medical Center Corporation |
Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid
|
US5922340A
(en)
|
1992-09-10 |
1999-07-13 |
Children's Medical Center Corporation |
High load formulations and methods for providing prolonged local anesthesia
|
US6162456A
(en)
*
|
1992-09-24 |
2000-12-19 |
Ortho-Mcneil Pharmaceutical, Inc. |
Adhesive transdermal drug delivery matrix of a physical blend of hydrophilic and hydrophobic polymers
|
US5989586A
(en)
*
|
1992-10-05 |
1999-11-23 |
Cygnus, Inc. |
Two-phase matrix for sustained release drug delivery device
|
US5573774A
(en)
*
|
1993-02-02 |
1996-11-12 |
Keenan; Robert M. |
Nicotine metabolites, nicotine dependence and human body weight
|
DE4313928C2
(de)
*
|
1993-04-28 |
1996-09-19 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System zur kontrollierten Abgabe von Pilocarpin an die Haut, Verfahren zu seiner Herstellung und seine Verwendung
|
US5505952A
(en)
*
|
1994-04-19 |
1996-04-09 |
United States Surgical Corporation |
Modified synthetic cross-linked amino acid polymers and medical devices formed therefrom
|
US5612027A
(en)
*
|
1995-04-18 |
1997-03-18 |
Galin; Miles A. |
Controlled release of miotic and mydriatic drugs in the anterior chamber
|
US5972326A
(en)
*
|
1995-04-18 |
1999-10-26 |
Galin; Miles A. |
Controlled release of pharmaceuticals in the anterior chamber of the eye
|
ATE267587T1
(de)
|
1995-06-09 |
2004-06-15 |
Euro Celtique Sa |
Formulierungen und verfahren für eine verlängerte lokalanästhesie
|
JPH11508943A
(ja)
*
|
1995-07-12 |
1999-08-03 |
コーニング インコーポレイテッド |
新規のフォトクロミック有機材料
|
US5723131A
(en)
|
1995-12-28 |
1998-03-03 |
Johnson & Johnson Vision Products, Inc. |
Contact lens containing a leachable absorbed material
|
JPH11511763A
(ja)
|
1996-06-24 |
1999-10-12 |
ユーロ―セルティーク,エス.エイ. |
安全な局所麻酔の提供方法
|
US6046187A
(en)
|
1996-09-16 |
2000-04-04 |
Children's Medical Center Corporation |
Formulations and methods for providing prolonged local anesthesia
|
JP2001503088A
(ja)
*
|
1996-10-11 |
2001-03-06 |
コーニング インコーポレイテッド |
有機フォトクロミック材料及び製法並びにこれを用いたフォトクロミック製品
|
AUPO379596A0
(en)
*
|
1996-11-22 |
1996-12-19 |
Soltec Research Pty Ltd |
Percutaneous delivery system
|
BR9815499A
(pt)
|
1997-07-02 |
2001-01-02 |
Euro Celtique Sa |
Anestesia prolongada nas juntas e nos espacos corporais.
|
US6514983B1
(en)
|
1997-09-03 |
2003-02-04 |
Guilford Pharmaceuticals Inc. |
Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
|
US6291425B1
(en)
|
1999-09-01 |
2001-09-18 |
Guilford Pharmaceuticals Inc. |
Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
|
US6635642B1
(en)
|
1997-09-03 |
2003-10-21 |
Guilford Pharmaceuticals Inc. |
PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
|
US6197785B1
(en)
|
1997-09-03 |
2001-03-06 |
Guilford Pharmaceuticals Inc. |
Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
|
US6426415B1
(en)
|
1997-09-03 |
2002-07-30 |
Guilford Pharmaceuticals Inc. |
Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity
|
US6346536B1
(en)
|
1997-09-03 |
2002-02-12 |
Guilford Pharmaceuticals Inc. |
Poly(ADP-ribose) polymerase inhibitors and method for treating neural or cardiovascular tissue damage using the same
|
US6395749B1
(en)
|
1998-05-15 |
2002-05-28 |
Guilford Pharmaceuticals Inc. |
Carboxamide compounds, methods, and compositions for inhibiting PARP activity
|
US6387902B1
(en)
|
1998-12-31 |
2002-05-14 |
Guilford Pharmaceuticals, Inc. |
Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP
|
US6410045B1
(en)
|
1999-02-22 |
2002-06-25 |
Clyde Lewis Schultz |
Drug delivery system for antiglaucomatous medication
|
US20020197300A1
(en)
*
|
1999-02-22 |
2002-12-26 |
Schultz Clyde L. |
Drug delivery system for anti-glaucomatous medication
|
ES2248107T3
(es)
|
1999-08-31 |
2006-03-16 |
Incyte San Diego Incorporated |
Benciliden-tiazolidindionas y analogos y su utilizacion en el tratamiento de la diabetes.
|
US6315987B1
(en)
*
|
2000-05-10 |
2001-11-13 |
Isp Investments Inc. |
Polymeric delivery and release systems for oral care actives
|
US6723733B2
(en)
|
2000-05-19 |
2004-04-20 |
Guilford Pharmaceuticals, Inc. |
Sulfonamide and carbamide derivatives of 6(5H)phenanthridinones and their uses
|
US6348475B1
(en)
|
2000-06-01 |
2002-02-19 |
Guilford Pharmaceuticals Inc. |
Methods, compounds and compositions for treating gout
|
US20040151755A1
(en)
*
|
2000-12-21 |
2004-08-05 |
Osman Rathore |
Antimicrobial lenses displaying extended efficacy, processes to prepare them and methods of their use
|
PL373912A1
(en)
|
2001-03-07 |
2005-09-19 |
Incyte San Diego, Inc. |
Heterocyclic derivatives for the treatment of cancer and other proliferative diseases
|
JP2004523571A
(ja)
*
|
2001-03-08 |
2004-08-05 |
マキシア・ファーマシューティカルズ・インコーポレイテッド |
Rxr活性化分子
|
CA2340824A1
(en)
*
|
2001-03-14 |
2002-09-14 |
Ibm Canada Limited-Ibm Canada Limitee |
Method and system for application behavior analysis
|
EP1421061A4
(de)
*
|
2001-08-17 |
2004-12-22 |
Incyte San Diego Inc |
Oximderivate für die behandlung von dyslipidämie und hypercholesterinämie
|
MXPA04004665A
(es)
|
2001-11-14 |
2004-09-10 |
Alza Corp |
Composiciones de deposito inyectable y uso de los mismos.
|
ES2329346T3
(es)
*
|
2001-11-14 |
2009-11-25 |
Durect Corporation |
Composicion de deposito inyectable.
|
EP1456187A4
(de)
|
2001-11-15 |
2005-02-09 |
Incyte San Diego Inc |
N-substituierte heterocyclen zur behandlung von hypercholesterinämie, dyslipidämie und anderen metabolischen störungen, krebs und anderen krankheiten
|
US7102000B2
(en)
*
|
2002-03-08 |
2006-09-05 |
Incyte San Diego Inc. |
Heterocyclic amide derivatives for the treatment of diabetes and other diseases
|
US7196108B2
(en)
*
|
2002-03-08 |
2007-03-27 |
Incyte San Diego Inc. |
Bicyclic heterocycles for the treatment of diabetes and other diseases
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
CN101057824A
(zh)
|
2002-07-31 |
2007-10-24 |
阿尔萨公司 |
可注射的多模式聚合物储库组合物以及其用途
|
NZ537955A
(en)
|
2002-07-31 |
2007-10-26 |
Alza Corp |
Injectable depot compositions and uses thereof
|
US7795203B2
(en)
*
|
2002-09-30 |
2010-09-14 |
Babizhayev Mark A |
Method for topical treatment of eye disease and composition and device for said treatment
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
WO2004066952A2
(en)
*
|
2003-01-29 |
2004-08-12 |
Incyte Corporation |
Benzoxazole, benzothiazole, and benzimidazole derivatives for the treatment of cancer and other diseases
|
CA2522759A1
(en)
*
|
2003-04-18 |
2004-11-04 |
Incyte San Diego Incorporated |
Substituted isochroman compounds for the treatment of metabolic disorders, cancer and other diseases
|
KR101161459B1
(ko)
*
|
2003-07-18 |
2012-07-02 |
도요 보세키 가부시키가이샤 |
아미노산 유도체 서방성 중합체, 이 중합체를 함유하는화장료 및 섬유 구조물, 및 이들의 제조방법 및 재생처리법
|
JP5105578B2
(ja)
|
2003-11-05 |
2012-12-26 |
サーコード バイオサイエンス インコーポレイテッド |
細胞接着のモジュレーター
|
US8236338B2
(en)
|
2004-07-13 |
2012-08-07 |
The University Of Tennessee Research Foundation |
Adhesive composition for carrying therapeutic agents as delivery vehicle on coatings applied to vascular grafts
|
MX2007005679A
(es)
*
|
2004-11-10 |
2007-07-11 |
Univ Columbia |
Metodo para tratamiento de desordenes de movimiento.
|
EP1812012A4
(de)
*
|
2004-11-15 |
2010-02-17 |
Ceptyr Inc |
Protein-tyrosin-phosphatasehemmer und verfahren zu ihrer verwendung
|
US9804295B2
(en)
†
|
2005-05-05 |
2017-10-31 |
Novartis Ag |
Ophthalmic devices for sustained delivery of active compounds
|
SI2444079T1
(sl)
|
2005-05-17 |
2017-05-31 |
Sarcode Bioscience Inc. |
Sestavki in postopki za zdravljenje očesnih motenj
|
JP5336180B2
(ja)
|
2005-05-23 |
2013-11-06 |
ナチュラル オータナティブス インターナショナル |
β−アラニンの徐放のための組成物及び方法
|
DE102006052342B4
(de)
*
|
2006-11-07 |
2015-08-20 |
Wöhlk-Contact-Linsen GmbH |
Kontaktlinsenmaterial
|
US8071119B2
(en)
*
|
2007-05-14 |
2011-12-06 |
Sustained Nano Systems Llc |
Controlled release implantable dispensing device and method
|
US20090148498A1
(en)
*
|
2007-05-14 |
2009-06-11 |
Sustained Nano Systems Llc |
Controlled release implantable dispensing device and method
|
US20080292680A1
(en)
*
|
2007-05-14 |
2008-11-27 |
Sustained Nano Systems Llc |
Hypercompressed polymer particles for controlled release ophthalmic medications
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
CA3089569C
(en)
|
2007-06-04 |
2023-12-05 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
CA2958665C
(en)
|
2007-10-19 |
2021-03-02 |
Sarcode Bioscience Inc. |
Compositions and methods for treatment of diabetic retinopathy
|
US20090258069A1
(en)
*
|
2008-04-15 |
2009-10-15 |
John Burnier |
Delivery of LFA-1 antagonists to the gastrointestinal system
|
WO2009139817A2
(en)
|
2008-04-15 |
2009-11-19 |
Sarcode Corporation |
Crystalline pharmaceutical and methods of preparation and use thereof
|
JP2011522828A
(ja)
|
2008-06-04 |
2011-08-04 |
シナジー ファーマシューティカルズ インコーポレイテッド |
胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
|
EP2321341B1
(de)
|
2008-07-16 |
2017-02-22 |
Synergy Pharmaceuticals Inc. |
Zur behandlung von erkrankungen des magen-darm-trakts, entzündlichen erkrankungen, krebs und anderen erkrankungen geeignete agonisten von guanylatcyclase
|
US9732324B2
(en)
|
2008-10-23 |
2017-08-15 |
Cornell University |
Anti-viral method
|
US10980818B2
(en)
|
2009-03-06 |
2021-04-20 |
Sun Pharma Global Fze |
Methods for treating ocular inflammatory diseases
|
US10201548B2
(en)
*
|
2009-03-06 |
2019-02-12 |
Sun Pharma Global Fze |
Methods for treating ocular inflammatory diseases
|
US8299079B2
(en)
|
2009-05-22 |
2012-10-30 |
Kaufman Herbert E |
Preparations and methods for ameliorating or reducing presbyopia
|
US8378105B2
(en)
|
2009-10-21 |
2013-02-19 |
Sarcode Bioscience Inc. |
Crystalline pharmaceutical and methods of preparation and use thereof
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
US8481591B2
(en)
|
2010-11-01 |
2013-07-09 |
Stiefel Research Australia Pty. Ltd. |
Polymeric topical compositions
|
JP6092849B2
(ja)
|
2011-05-04 |
2017-03-08 |
バランス セラピューティックス, インコーポレイテッドBalance Therapeutics, Inc. |
ペンチレンテトラゾール誘導体
|
US20130004651A1
(en)
*
|
2011-07-01 |
2013-01-03 |
Patty Fu-Giles |
Sustained drug release from body implants using nanoparticle-embedded polymeric coating materials
|
EP2877465A4
(de)
|
2012-07-25 |
2016-05-11 |
Sarcode Bioscience Inc |
Lfa-1-hemmer und polymorph davon
|
EP2912121B1
(de)
|
2012-10-29 |
2019-09-25 |
Ariste Medical, LLC |
Polymerbeschichtungszusammensetzungen und beschichtete gegenstände
|
US9545446B2
(en)
|
2013-02-25 |
2017-01-17 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase and their uses
|
US9486494B2
(en)
|
2013-03-15 |
2016-11-08 |
Synergy Pharmaceuticals, Inc. |
Compositions useful for the treatment of gastrointestinal disorders
|
EP2970384A1
(de)
|
2013-03-15 |
2016-01-20 |
Synergy Pharmaceuticals Inc. |
Agonisten der guanylatcyclase und deren verwendungen
|
EP3054969B1
(de)
|
2013-10-10 |
2021-03-10 |
Bausch Health Ireland Limited |
Gunaylatcyclase-cyclase-agonisten zur behandlung von opioidinduzierten störungen
|
US20160303242A1
(en)
|
2013-12-09 |
2016-10-20 |
Durect Corporation |
Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same
|
EP3134482B1
(de)
|
2014-04-22 |
2020-06-03 |
Ariste Medical, LLC |
Verfahren und prozesse zur anwendung von wirkstofffreisetzungspolymerbeschichtungen
|
EP3291886A1
(de)
|
2015-05-04 |
2018-03-14 |
Ecole Polytechnique Federale de Lausanne (EPFL) |
Ophthalmische kontaktlinse mit komprimierbarer affinitätsmatrix
|
CN108884130B
(zh)
|
2016-01-11 |
2022-09-13 |
博士医疗爱尔兰有限公司 |
用于治疗溃疡性结肠炎的制剂和方法
|
PT109154B
(pt)
|
2016-02-12 |
2019-11-05 |
Univ De Coimbra |
Tecnologia não-invasiva de inserto ocular para libertação controlada de fármacos
|
KR20220140711A
(ko)
|
2020-01-13 |
2022-10-18 |
듀렉트 코퍼레이션 |
불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법
|